Results
158
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
158 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BABA | US$132.54 | 1.3% | 77.1% | US$317.8b | US$160.38 | PE18.1x | E10.1% | 0.7% | Retail | ||
QCOM | US$154.98 | 0.9% | -9.4% | US$178.2b | US$198.50 | PE16.3x | E5.4% | 2.2% | Semiconductors | ||
AMP | US$480.37 | -9.7% | 16.7% | US$48.0b | US$567.36 | PE13.6x | E4.4% | 1.2% | Diversified Financials | ||
HIG | US$117.35 | -2.0% | 19.6% | US$33.6b | US$128.71 | PE10.8x | E6.3% | 1.8% | Insurance | ||
BIDU | US$92.59 | 9.8% | -8.6% | US$33.2b | US$110.00 | PE9.9x | E1.9% | n/a | Media | ||
CNC | US$59.44 | 1.5% | -23.8% | US$29.8b | US$78.62 | PE8.9x | E4.7% | n/a | Healthcare | ||
RJF | US$137.62 | -8.5% | 15.8% | US$29.4b | US$175.80 | PE13x | E5.8% | 1.5% | Diversified Financials | ||
DOV | US$177.74 | -8.0% | 4.0% | US$25.5b | US$219.75 | PE17.4x | E-2.1% | 1.2% | Capital Goods | ||
MKL | US$1,835.80 | -4.3% | 22.3% | US$24.2b | US$1,861.83 | PE9x | E-6.8% | n/a | Insurance | ||
WRB | US$62.96 | -1.2% | 11.2% | US$23.7b | US$63.88 | PE13.6x | E2.4% | 2.2% | Insurance | ||
BIIB | US$150.71 | 6.4% | -34.5% | US$22.0b | US$201.18 | PE13.5x | E7.6% | n/a | Pharmaceuticals & Biotech | ||
CINF | US$138.46 | -6.1% | 18.0% | US$21.9b | US$155.33 | PE9.5x | E-31.0% | 2.5% | Insurance | ||
HPE | US$15.08 | -20.8% | -16.4% | US$20.8b | US$21.13 | PE7.2x | E0.6% | 3.4% | Tech | ||
KSPI | US$97.50 | -5.4% | -7.3% | US$19.3b | US$131.54 | PE8.7x | E16.0% | 0% | Diversified Financials | ||
DECK New | US$121.11 | -11.8% | -19.4% | US$19.2b | US$216.70 | PE19.5x | E7.0% | n/a | Consumer Durables | ||
KOF | US$84.95 | -2.4% | -12.0% | US$18.1b | US$109.43 | PE15.3x | E9.2% | 3.5% | Food, Beverage & Tobacco | ||
ICLR | US$182.72 | -1.1% | -45.0% | US$15.1b | US$249.35 | PE18.6x | E9.6% | n/a | Pharmaceuticals & Biotech | ||
CSL | US$335.56 | 0.8% | -6.0% | US$14.9b | US$451.67 | PE17.3x | E8.0% | 1.2% | Capital Goods | ||
HOLX | US$65.62 | 3.7% | -14.0% | US$14.5b | US$79.91 | PE19.8x | E8.5% | n/a | Healthcare | ||
RL New | US$218.40 | -16.8% | 22.4% | US$14.4b | US$292.13 | PE19.1x | E8.1% | 1.5% | Consumer Durables | ||
UTHR | US$317.87 | 2.5% | 27.4% | US$14.2b | US$400.54 | PE11.9x | E8.1% | n/a | Pharmaceuticals & Biotech | ||
UNM | US$77.33 | -5.0% | 53.6% | US$14.0b | US$91.85 | PE7.7x | E-2.3% | 2.2% | Insurance | ||
LBRD.K | US$84.54 | 0.2% | 42.7% | US$12.5b | US$101.60 | PE13.9x | E34.0% | n/a | Media | ||
SF | US$91.62 | -11.5% | 23.4% | US$10.0b | US$125.75 | PE13.7x | E16.6% | 2.0% | Diversified Financials |